MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for ...

The wider tau-targeting pipeline meanwhile includes a handful of phase 3 candidates, including Eisai's antibody-based E-2814 and small-molecule drugs from Annovis Bio (buntanetap), BioVie ...

Other clinical-stage drugs in the category include: Annovis Bio's buntanetap, an oral drug targeting alpha-synuclein, amyloid, and tau proteins that generated preliminary positive results in a ...

Israel says it has killed thousands of the armed group’s members and destroyed much of its infrastructure, but since the cease-fire started Hamas has shown it still holds power in the enclave ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.

Ukrainian forces described a different kind of enemy, fighting with unfamiliar tactics and little option to retreat. By Marc Santora and Helene Cooper Rupert Murdoch’s News Group Newspapers ...